Visualizza il programma dell'evento
Conferimento Lauree ad Honorem in Medicina e Chirurgia (video)
Conferimento Lauree ad Honorem in Medicina e Chirurgia (foto)
Visualizza gli interventi ed i video dell'evento
Visualizza le foto dell'evento
Materiale Didattico
- ARIA
- GINA
- comorbidità
- asma grave
- The prevalence of non-adherence in difficult asthma
- Qualitative Analysis of High-Resolution CT Scans in Severe Asthma
- Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma
- Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction
- "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
- Identification of Asthma Phenotypes using Cluster Analysis in the Severe Asthma Research Program
- Phenotypic determinants of uncontrolled asthma
- Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
- educazione
- epidemiologia e fattori di rischio
- Control of asthma for reducing the risk of bronchospasm in asthmatics undergoing general anesthesia and/or intravascular administration of radiographic contrast media
- Is the prevalence of asthma declining? Systematic review of epidemiological studies
- Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis
- Genetics of Asthma - Where Are We and Where Do We Go?
- Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC)
- Modifiche a diapositive
- fisiopatologia
- Intrinsic asthma: not so different from allergic asthma but driven by superantigens?
- Noninflammatory mechanisms of airway hyper-responsiveness in bronchial asthma: an overview
- Innate Cells and T Helper 2 Cell Immunity in Airway Inflammation
- Increased airway closure is a determinant of airway hyperresponsiveness
- Eosinophilic and Neutrophilic Inflammation in Asthma
- The development of allergic inflammation
- The importance and features of the distal airways in children and adults
- Immunobiology of Asthma
- House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells
- Immunity
- Rethinking the Pathogenesis of Asthma
- A new look at the pathogenesis of asthma
- Has the time come to rethink the pathogenesis of asthma?
- Anatomy, pathology, and physiology of the tracheobronchial tree: Emphasis on the distal airways
- Biology of Lung Dendritic Cells at the Origin of Asthma
- Dust mites’ dirty dealings in the lung
- Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma
- Regulatory T cells in bronchial asthma
- Asma: dalla fisiopatologia alla clinica
- Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses
- nuove terapie
- Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma
- Novel bronchodilators in asthma
- Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- Eosinophils in Asthma — Closing the Loop or Opening the Door?
- pediatria
- ASMA IN PEDIATRIA
- The role of inhaled corticosteriods and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis
- Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma
- Prenatal Tobacco Smoke Exposure Affects Global and Gene-specific DNA Methylation
- Phenotypic Differences between Pediatric and Adult Asthma
- Efficacy of Inhaled Corticosteroids in Infants and Preschoolers With Recurrent Wheezing and Asthma: A Systematic Review With Meta-analysis
- Ciclesonide versus other inhaled steroids for chronic asthma in children and adults (Review)
- Preemptive Use of High-Dose Fluticasone for Virus-Induced Wheezing in Young Children
- Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
- Oral Prednisolone for Preschool Children with Acute Virus-Induced Wheezing
- Regular vs prn nebulized treatment in wheeze preschool children
- Dietary antioxidant intake, allergic sensitization and allergic diseases in young children
- Dispensing of fluticasone propionate/salmeterol combination in the summer and asthma-related outcomes in the fall
- riacutizzazioni
- LE RIACUTIZZAZIONI ASMATICHE
- Intubation and Mechanical Ventilation of the Asthmatic Patient in Respiratory Failure
- Managing asthma exacerbations in the emergency department: Summary of the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines for the management of asthma exacerbations
- Managing Asthma Exacerbations in the Emergency Department
- Acute exacerbations of asthma: epidemiology, biology and the exacerbationprone phenotype
- Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma
- Severe Exacerbations and Decline in Lung Function in Asthma
- Follow-up after acute asthma episodes: What improves future outcomes?
- terapia
- Il controllo dell'asma
- Asthma in Pregnancy
- Ciclesonide versus other inhaled steroids for chronic asthma in children and adults (Review)
- Ciclesonide versus placebo for chronic asthma in adults and children (Review)
- Budesonide/formoterol maintenance and reliever therapy versus conventional best practice
- Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma
- Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials
- High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations
- Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
- Terapia farmacologica
- GOLD
- Definizione
- Definizione ed aspetti sistemici
- Classificazione di gravità
- Epidemiologia
- Epidemiologia e costi della BPCO
- Fattori di rischio
- The COPD genetic association compendium: a comprehensive online database of COPD genetic associations
- Chronic obstructive pulmonary disease in non-smokers
- Fattori di rischio : Messaggi principali
- Laboratory diagnosis of alpha1-antitrypsin deficiency
- Diagnosi_AATD_Gold_2010
- fattori di rischio bpco 2010
- Anatomia patologica, patogenesi e fisiopatologia
- Anatomia patologica e patogenesi
- Diagnosi e monitoraggio
- Screening ed inquadramento diagnostico
- Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular Filling
- Classifying the severity of COPD: are the new severity scales better than the old?
- THE RATIO OF FORCED EXPIRATORY VOLUME IN 1-SECOND TO FORCED VITAL CAPACITY AS A BASIS FOR ESTABLISHING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- Defining chronic obstructive pulmonary disease in older persons
- Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study
- Modena-GOLD2010
- Imaging e caratterizzazione fenotipica
- Screening ed inquadramento diagnostico
- Riduzione dei fattori di rischio
- Azioni contro il fumo di sigaretta ed altre azioni preventive
- Trattamento della BPCO stabile
- Trattamento farmacologico della BPCO stabile
- Cardiovascular Safety of Tiotropium in Patients With COPD
- Anticholinergic Drugs for the Treatment of COPD Are Safe...Are They?
- ERS-ATS COPD Guidelines
- Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
- La scomparsa dello stadio 0 della BPCO nelle Linee Guida GOLD 2006
- Chronic Obstructive Pulmonary Disease: Management of adults 8 with chronic obstructive pulmonary disease in primary and 9 secondary care
- Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study
- COPD recommendations - 2008 Primary care update
- BPCO terapia 2009
- Proposte LG GOLD Italia 2010
- Mortality in the 4-Year Trial of Tiotropium (UPLIFT) in Patients with Chronic Obstructive Pulmonary Disease
- Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecifi ed subgroup analysis of a randomised controlled trial
- RCP Spiriva dicembre 2009
- Trattamento farmacologico degli aspetti sistemici e delle comorbilità
- Trattamento non farmacologico della BPCO stabile
- Educazione del paziente e somministrazione dei farmaci
- Markers ed outcomes di malattia e delle riacutizzazioni
- Trattamenti Chirurgici ed endoscopici della BPCO
- Trattamento farmacologico della BPCO stabile
- Gestione delle riacutizzazioni
- Diagnosi e gestione clinica delle riacutizzazioni
- Gestione delle riacutizzazioni
- Diagnosi e gestione clinica delle riacutizzazioni
- Trattamento intensivo respiratorio
- Linee Guida nelle cure primarie - Adattamento delle Linee Guida alla medicina generale
- Implementazione delle linee Guida
- Nuovi trattamenti
- Indacaterolo
- GOLD 2010 - New treatments in COPD
- Emerging Pharmacotherapies for COPD
- Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design
- Bronchodilator effects of indacaterol and formoterol in patients with COPD
- Rofl umilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
- Rofl umilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
- The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
- First Study of Infliximab Treatment in Patients with Chronic Obstructive Pulmonary Disease
- Indacaterol, a Novel Inhaled, Once-Daily, Long-Acting Beta2-Agonist for the Treatment of Obstructive Airways Diseases
- Nuovi trattamenti per la BPCO
- Definizione
- Slide Kit 2009
- Guida 2009